Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at ...

Fintel reports that on February 28, 2025, Piper Sandler upgraded their outlook for CAVA Group (NYSE:CAVA) from Neutral to ...

Piper Sandler upgraded CAVA Group Inc (NYSE:CAVA) to “Overweight” from “Neutral” following a sharp pullback in its stock given strong fundamentals and long-term growth potential in the fast-casual ...

Piper Sandler analyst Brian Mullan upgraded Cava Group (CAVA) to Overweight from Neutral with a price target of $115, down from $142. The firm ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Piper Sandler bond chief Jeremy Goebel at his desk on the trading floor Tuesday, Feb. 4. (Aaron Lavinsky/The Minnesota Star Tribune) ...

Piper Sandler analyst David Westenberg maintained a Buy rating on Illumina (ILMN – Research Report) today and set a price target of $190.00.

Piper Sandler began coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a research note issued on Friday, MarketBeat reports. The firm set an “overweight” rating and a $48.00 ...

Zoetis (NYSE:ZTS – Get Free Report) had its target price increased by equities researchers at Piper Sandler from $200.00 to $205.00 in a report issued on Thursday,Benzinga reports. The brokerage ...

Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at Neutral. Analyst Brian Mullan and his team see CAVA (NYSE:CAVA ...

Fintel reports that on February 28, 2025, Piper Sandler upgraded their outlook for CAVA Group (NYSE:CAVA) from Neutral to Overweight. As of February 19, 2025, the average one-year price target for ...